Strength
2 mg/1
Manufacturer
AvPAKNDC
50268048215
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LOPERAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215579On Market Since
4/5/2023
Pharmacological Classes
Price Statistics
The NADAC for LOPERAMIDE 2 MG CAPSULE has been published 142 times since Oct 11, 2023, and over the history we have for it it has declined 78.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0541 per EA |
|---|---|
| All-time high | $0.2541 (Dec 13, 2023) |
| All-time low | $0.0520 (Feb 18, 2026) |
| 52-week high | $0.1160 |
| 52-week low | $0.0520 |
| Median price | $0.1254 |
| Average price | $0.1356 |
| Largest weekly change | +44.3% (Aug 21, 2024) |
| Weeks tracked | 142 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LOPERAMIDE 2 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LOPERAMIDE 2 MG CAPSULE, manufactured by AvPAK, is $0.0541 per EA (NDC 50268048215), effective Jun 24, 2026.
How has the price of LOPERAMIDE 2 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LOPERAMIDE 2 MG CAPSULE has declined 78.5%. It has been tracked across 142 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for LOPERAMIDE 2 MG CAPSULE?
Since Oct 11, 2023, the NADAC for LOPERAMIDE 2 MG CAPSULE has ranged from a low of $0.0520 (Feb 18, 2026) to a high of $0.2541 (Dec 13, 2023), with a median of $0.1254 per EA.
Are there cheaper alternatives to LOPERAMIDE 2 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as LOPERAMIDE 2 MG CAPSULE, but none are currently priced below it.
Who manufactures LOPERAMIDE 2 MG CAPSULE?
LOPERAMIDE 2 MG CAPSULE (NDC 50268048215) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification